Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 133Precursor Cell Lymphoblastic Leukemia-Lymphoma 118Myelodysplastic Syndromes 107Lymphoma, Non-Hodgkin 90Leukemia, Lymphocytic, Chronic, B-Cell 85Hodgkin Disease 84Leukemia 81Multiple Myeloma 80Lymphoma, Mantle-Cell 63Lymphoma 63Lymphoma, Follicular 59Leukemia, Myelogenous, Chronic, BCR-ABL Positive 59Myeloproliferative Disorders 55Lymphoma, B-Cell, Marginal Zone 53Leukemia, Myelomonocytic, Chronic 50Burkitt Lymphoma 50Lymphoma, Large B-Cell, Diffuse 49Hematologic Neoplasms 42Congenital Abnormalities 42Lymphoma, Large-Cell, Immunoblastic 36Leukemia, Myeloid, Accelerated Phase 35Leukemia, Myeloid, Chronic-Phase 34Anemia, Refractory, with Excess of Blasts 34Waldenstrom Macroglobulinemia 33Primary Myelofibrosis 32Leukemia, Biphenotypic, Acute 32Lymphoma, Large-Cell, Anaplastic 28Blast Crisis 28Lymphoma, T-Cell, Cutaneous 27Dendritic Cell Sarcoma, Interdigitating 26

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Malignant Neoplasm × Whole-Body Irradiation × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡